Stroke and mortality risk in patients with various patterns of atrial fibrillation: results from the ENGAGE AF-TIMI 48 trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48) - Link, M S; Giugliano, R P; Ruff, C T (Circ Arrhythm Electrophysiol, 2017)
, et al; ENGAGE AF-TIMI 48 Investigators.